Utility of the rapid B-type natriuretic peptide assay for detection of cardiovascular problems in newborn infants with respiratory difficulties

Neonatology

Volumn 94, Issue 1, 2008, Pages 16-21

  Ko, Hong Ki ^a   Lee, Jang Hoon ^a   Choi, Byung Min ^a,b   Lee, Jung Hwa ^a   Yoo, Kee Hwan ^a   Son, Chang Sung ^a   Lee, Joo Won ^a  

^a Korea University College of Medicine   (South Korea)

^b Korea University Ansan Hospital   (South Korea)

Author keywords

B type natriuretic peptide; Cardiovascular problem; Newborn infant; Respiratory difficulty

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ARTICLE; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEWBORN SCREENING; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; SCREENING TEST; SENSITIVITY ANALYSIS;

AORTIC COARCTATION; CARDIOVASCULAR DISEASES; DUCTUS ARTERIOSUS, PATENT; FEMALE; HEART SEPTAL DEFECTS, ATRIAL; HUMANS; INFANT, NEWBORN; LUNG DISEASES; MALE; NATRIURETIC PEPTIDE, BRAIN; NEONATAL SCREENING; PULMONARY EDEMA; PULMONARY VALVE STENOSIS; RESPIRATORY DISTRESS SYNDROME, NEWBORN; SENSITIVITY AND SPECIFICITY;

EID: 46049117508     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000112584     Document Type: Article

References (21)

1. Sasidharan P: An approach to diagnosis and management of cyanosis and tachypnea in term infants. Pediatr Clin North Am 2004;51:999-1021.
2. Dao Q, Krishnaswamy P, Kazanegra R, Harrison A, Amirnovin R, Lenert L, Clopton P, Alberto J, Hlavin P, Maisel AS: Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. J Am Coll Cardiol 2001;37:379-385.
3. Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel A: Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002;39:202-209.
4. Koulouri S, Acherman RJ, Wong PC, Chan LS, Lewis AB: Utility of B-type natriuretic peptide in differentiating congestive heart failure from lung disease in pediatric patients with respiratory distress. Pediatr Cardiol 2004;25:341-346.
5. Choi BM, Lee KH, Eun BL, Yoo KH, Hong YS, Son CS, Lee JW: Utility of rapid B-type natriuretic peptide assay for diagnosis of symptomatic patent ductus arteriosus in preterm infants. Pediatrics 2005;115:e255-e261.
6. Lin NC, Landt ML, Trinkaus KM, Balzer DT, Kort HW, Canter CE: Relation of age, severity of illness, and hemodynamics with brain natriuretic peptide levels in patients <20 years of age with heart disease. Am J Cardiol 2005;96:847-850.
7. Ohuchi H, Takasugi H, Ohashi H, Okada Y, Yamada O, Ono Y, Yagihara T, Echigo S: Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation 2003;108:2368-2376.
8. Kunii Y, Kamada M, Ohtsuki S, Araki T, Kataoka K, Kageyama M, Nakagawa N, Seino Y: Plasma brain natriuretic peptide and the evaluation of volume overload in infants and children with congenital heart disease. Acta Med Okayama 2003;57:191-197.
9. Suda K, Matsumura M, Matsumoto M: Clinical implication of plasma natriuretic peptides in children with ventricular septal defect. Pediatr Int 2003;45:249-254.
10. Muta H, Ishii M, Maeno Y, Akagi T, Kato H: Quantitative evaluation of the changes in plasma concentrations of cardiac natriuretic peptide before and after transcatheter closure of atrial septal defect. Acta Paediatr 2002;91:649-652.
11. Reynolds EW, Ellington JG, Vranicar M, Bada HS: Brain-type natriuretic peptide in the diagnosis and management of persistent pulmonary hypertension of the newborn. Pediatrics 2004;114:1297-1304.
12. Nasser N, Bar-Oz B, Nir A: Natriuretic peptides and heart disease in infants and children. J Pediatr 2005;147:248-253.
13. Nir A, Nasser N: Clinical value of NT-Pro BNP and BNP in pediatric cardiology. J Card Fail 2005;11:S76-S80.
14. Koch A, Singer H: Normal values of B type natriuretic peptide in infants, children, and adolescents. Heart 2003;89:875-878.
15. Yoshibayashi M, Kamiya T, Saito Y, Nakao K, Nishioka K, Temma S, Itoh H, Shirakami G, Matsuo H: Plasma brain natriuretic peptide concentrations in healthy children from birth to adolescence: marked and rapid increase after birth. Eur J Endocrinol 1995;133:207-209.
16. Holmstrom H, Hall C, Thaulow E: Plasma levels of natriuretic peptides and hemodynamic assessment of patent ductus arteriosus in preterm infants. Acta Paediatr 2001;90:184-191.
17. Puddy VF, Amirmansour C, Williams AF, Singer DR: Plasma brain natriuretic peptide as a predictor of haemodynamically significant patent ductus arteriosus in preterm infants. Clin Sci (Lond) 2002;103:75-77.
18. da Graca RL, Hassinger DC, Flynn PA, Sison CP, Nesin M, Auld PA: Longitudinal changes of brain-type natriuretic peptide in preterm neonates. Pediatrics 2006;117:2183-2189.
19. Yoon YS, Lee J, Je BK, Eun SH, Kim HJ, Choi BM, Park JT, Yoo KH, Hong YS, Choi CH: Usefulness of plasma B-type natriuretic peptide assay as a screening tool for infants with suspected congenital heart disease. J Korean Soc Neonatol 2005;12:141-149.
20. Westerlind A, Wahlander H, Lindstedt G, Lundberg PA, Holmgren D: Clinical signs of heart failure are associated with increased levels of natriuretic peptide types B and A in children with congenital heart defects or cardiomyopathy. Acta Paediatr 2004;93:340-345.
21. Koch A, Zink S, Singer H: B-type natriuretic peptide in paediatric patients with congenital heart disease. Eur Heart J 2006;27:861-866.